Menstrual effluent in endometriosis shows no difference in volume, VEGF-A, MMP2 and MMP9 or sFLT

Reproductive BioMedicine Online

Volumn 12, Issue 2, 2006, Pages 174-181

  Malik, Shazia ^a   Day, Kate ^b   Perrault, Isabelle ^b   Charnock Jones, D Stephen ^c   Smith, Stephen K ^d  

^a Napolitano and Prof David)   (United Kingdom)

^b Paradigm Therapeutics LTD   (United Kingdom)

^c DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Angiogenesis; Endometriosis; Menstrual effluent; MMP; sFLT; VEGF A

Indexed keywords

GELATINASE A; GELATINASE B; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ADULT; ANGIOGENESIS; ARTICLE; BLEEDING; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LAPAROSCOPY; MENSTRUAL CYCLE; MENSTRUATION; PATHOPHYSIOLOGY; PATIENT SELECTION; PERITONEAL FLUID; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

EID: 33144485087     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60858-9     Document Type: Article

References (50)

1. Bhanoori M, Arvind Babu K, Pavankumar Reddy NG et al. 2005 The vascular endothelial growth factor (VEGF) +405G>C 5′-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study. Human Reproduction 20, 1844-1849.
2. Bruner KL, Matrisian LM, Rodgers WH et al. 1997 Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. The Journal of Clinical Investigation 99, 2851-2857.
3. Bruner-Tran KL, Eisenberg E, Yeaman GR et al. 2002a Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. Journal of Clinical Endocrinology and Metabolism 87, 4782-4791.
4. Bruner-Tran KL, Webster-Clair D, Osteen KG 2002b Experimental endometriosis: the nude mouse as a xenographic host. Annals of the New York Academy of Sciences 955, 328-339; discussion 340-322, 396-406.
5. Bulletti C, Flamigni C, De Ziegler D 2005 Implantation markers and endometriosis. Reproductive BioMedicine Online 11, 464-468.
6. Burbridge MF, Coge F, Galizzi JP et al. 2002 The role of the matrix metalloproteinases during in vitro vessel formation. Angiogenesis 5, 215-226.
7. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162, 156-159.
8. Chung HW, Lee JY, Moon HS et al. 2002 Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic, endometrium. Fertility and Sterility 78, 787-795.
9. Chung HW, Wen Y, Chun SH et al. 2001 Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness. Fertility and Sterility 75, 152-159.
10. Collette T, Bellehumeur C, Kats R et al. 2004 Evidence for an increased release of proteolytic activity by the eutopic, endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9. Human Reproduction 19, 1257-1264.
11. Cornet PB, Galant C, Eeckhout Y et al. 2005 Regulation of matrix metalloproteinase-9/gelatinase B expression and activation by ovarian steroids and LEFTY-A/endometrial bleeding-associated factor in the human endometrium. Journal of Clinical Endocrinology and Metabolism 90, 1001-1011.
12. Donnez J, Smoes P, Gillerot S et al. 1998 Vascular endothelial growth factor (VEGF) in endometriosis. Human Reproduction 13, 1686-1690.
13. Evers JL, Dunselman GA, Groothuis P 2005 Now you see them, now you don't. Fertility and Sterility 84, 31-32; discussion 38-39.
14. Eyster KM, Boles AL, Brannian JD, Hansen KA 2002 DNA microarray analysis of gene expression markers of endometriosis. Fertility and Sterility 77, 38-42.
15. Freitas S, Meduri G, Le Nestour E et al. 1999 Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium. Biology of Reproduction 61, 1070-1082.
16. Gannon MJ, Day P, Hammadieh N, Johnson N 1996 A new method for measuring menstrual blood loss and its use in screening women before endometrial ablation. British Journal of Obstetrics and Gynaecology 103, 1029-1033.
17. Gescher DM, Siggelkow W, Meyhoefer-Malik A, Malik E 2005 A priori implantation potential does not differ in eutopic endometrium of patients with and without endometriosis. Archives of Gynecology and Obstetrics 272, 117-123.
18. Halme J, Hammond MG, Hulka JF et al. 1984 Retrograde menstruation in healthy women and in patients with endometriosis. Obstetrics and Gynecology 64, 151-154.
19. Haynes DM, Wolfe WM 1970 Tubal sterilization in an indigent population. Report of fourteen years' experience. American Journal of Obstetrics and Gynecology 106, 1044-1053.
20. Hsieh YY, Chang CC, Tsai FJ et al. 2004 T allele for VEGF gene-460 polymorphism at the 5′-untranslated region: association with a higher susceptibility to endometriosis. Journal of Reproductive Medicine 49, 468-472.
21. Huang HF, Hong LH, Tan Y, Sheng JZ 2004 Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis. Fertility and Sterility 81, 1235-1239.
22. Hull ML, Charnock-Jones DS, Chan CL et al. 2003 Antiangiogenic agents are effective inhibitors of endometriosis. Journal of Clinical Endocrinology and Metabolism 88, 2889-2899.
23. Kao LC, Germeyer A, Tulac, S et al. 2003 Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 144, 2870-2881.
24. Koks CA, Demir Weusten AY, Groothuis PG et al. 2000a Menstmum. induces changes in mesothelial cell morphology. Gynecologic and Obstetric Investigation 50, 13-18.
25. Koks CA, Groothuis PG, Slaats P et al. 2000b Matrix metalloproteinases and their tissue inhibitors in antegradely shed menstrumn and peritoneal fluid. Fertility and Sterility 73, 604-612.
26. Liu DT, Hitchcock A 1986 Endometriosis: its association with retrograde menstruation, dysmenorrhoea and tubal pathology. British Journal of Obstetrics and Gynaecology 93, 859-862.
27. Maeda N, Izumiya C, Yamamoto Y et al. 2002 Increased killer inhibitory receptor KIR2DL1 expression among natural killer cells in women with pelvic endometriosis. Fertility and Sterility 77, 297-302.
28. McLaren J, Prentice A, Charnock-Jones DS et al. 1997 Immunolocalization of the apoptosis regulating proteins Bcl-2 and Bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis. Human Reproduction 12, 146-152.
29. McLaren J, Prentice A, Charnock-Jones DS et al. 1996a Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. Journal of Clinical Investigation 98, 482-489.
30. McLaren J, Prentice A, Charnock-Jones DS et al. 1996b In situ hybridization and immunocytochemical localization of vascular endothelial growth factor in ectopic endometrial tissue and activated peritoneal macrophages. Journal of Clinical Investigation 98, 482-489.
31. McLaren J, Prentice A, Charnock-Jones DS, Smith SK 1996c Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Human Reproduction 11, 220-223.
32. Nap AW, Dunselman GA, de Goeij AF et al. 2004a Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model. Human Reproduction 19, 2180-2187.
33. Nap AW, Griffioen AW, Dunselman GA et al. 2004b Antiangiogenesis therapy for endometriosis. Journal of Clinical Endocrinology and Metabolism 89, 1089-1095.
34. Olive DL, Henderson DY 1987 Endometriosis and mullerian anomalies. Obstetrics and Gynecology 69, 412.
35. Print C, Valtola R, Evans A et al. 2004 Soluble factors from human endometrium promote angiogenesis and regulate the endothelial cell transcriptome. Human Reproductive 19, 2356-2366.
36. Ria R, Loverro G, Vacca A et al. 2002 Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 agree with progression of ovarian endometriomas. European Journal of Clinical Investigation 32, 199-206.
37. Sampson JA 1921 Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. American Journal of Obstetrics and Gynecology 14, 422-469.
38. Sharkey AM, Day K, McPherson A et al. 2000 Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. Journal of Clinical Endocrinology and Metabolism 85, 402-409.
39. Simpson JL, Cooper JC, Bamforth JR et al. 1996 Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies-complicated by pre-eclempsia. European Journal of Clinical Investigation 26, 1182-1185.
40. Simpson JL, Bischoff F 2003 Heritability and candidate genes for endometriosis. Reproductive BioMedicine Online 7, 162-169.
41. Soini Y, Alarakkola E, Autio-Harmainen H 1997 Expression of messenger RNAs for metalloproteinases 2 and 9, type IV collagen, and laminin in nonneoplastic and neoplastic endometrium. Human Pathology 28, 220-226.
42. Szyllo K, Tchorzewski H, Banasik M et al. 2003 The involvement of T lymphocytes in the pathogenesis of endometriotic tissues overgrowth in women with endometriosis. Mediators of Inflammation 12, 131-138.
43. Takehara M, Ueda M, Yamashita Y et al. 2004 Vascular endothelial growth factor A and C gene expression in endometriosis. Human Pathology 35, 1369-1375.
44. Tan XJ, Lang JH, Liu DY et al. 2002 Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertility and Sterility 78, 148-153.
45. Vercellini P, De Giorgi O, Aimi G et al. 1997 Menstrual characteristics i in women with and without endometriosis. Obstetrics and Gynecology 90, 264-268.
46. Vu TH, Shipley JM, Bergers G et al. 1998 MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422.
47. Wary KK, Thakker GD, Humtsoe JO, Yang J 2003 Analysis of VEGF-responsive genes involved in the activation of endothelial cells. Molecular Cancer 2, 25.
48. Weil SJ, Wang S, Perez MC, Lyttle CR 1997 Chemotaxis of macrophages by a peritoneal fluid protein in women with endometriosis. Fertility and Sterility 67, 865-869.
49. Witz CA, Dechaud H, Montoya-Rodriguez IA et al. 2002 An in vitro model to study the pathogenesis of the early endometriosis lesion. Annals of the New York Academy of Sciences 955, 296-307; discussion 340-292, 396-406.
50. Zhang J, Salamonsen LA 2002 In vivo evidence for active matrix metalloproteinases in human endometrium supports their role in tissue breakdown at menstruation. Journal of Clinical Endocrinology and Metabolism 87, 2346-2351.